Q: Are Purebred or Mixed-Breed Dogs Healthier? A: “While any breed of pet can become ill, some purebred dogs are closely inbred and can have a greater risk of developing genetic diseases or congenital issues that come from inbreeding,” said Dr. Liff. While every pet’s health is unique, purebred dogs have less genetic diversity than mixed-breed dogs and are generally at a higher risk for genetic or inherited medical conditions. Mixed-breed dogs have a more diverse genetic pool, so if one dog has a health issue, the chances are higher it will disappear in the next generation. Responsible breeders can reduce the risk of some of the more prevalent genetic diseases by doing specific disease testing before breeding a dog, but not all breeders invest the time and money to do this. Only buy from reputable breeders who test for common genetic diseases to ensure your puppy is healthy. Q: What Health Problems Do Purebred Dogs Have? A: Purebred dogs are at a higher risk for a variety of hereditary and congenital conditions. “Some examples are that Cavalier King Charles spaniels have a higher risk of heart disease, as do boxers, Great Danes and Doberman pinschers,” said Dr. Liff. “Doberman pinschers also often have a blood clotting disorder called Von Willebrand’s disease. Purebred poodles can have increased prevalence of epilepsy and Addison’s disease.” Hereditary conditions are genetically inherited, and may not appear until later life. Congenital defects develop while the pet is still in utero, and while these conditions are present at birth, they may not be apparent without a veterinary exam. Common hereditary conditions — Hip and elbow dysplasia, heart disease, epilepsy and certain eye conditions Common congenital conditions — Heart defects, liver abnormalities and cleft palate Q: Are Purebred or Mixed-Breed Dogs More Expensive To Own? A: Owning any pet is a big financial commitment. While the cost of owning a dog varies, popular breeds, such as French bulldogs, are expensive to purchase and are more prone to certain genetic disorders, which can increase their healthcare costs. Breed-related conditions can range from mild to severe and may require costly lifelong medical management (i.e., medication, rehabilitation or weight management) or surgical correction. Q: Are Purebred Dogs More Expensive To Insure? A: While breed is factored into the cost of coverage, pet insurance premiums are based on multiple other factors. “Insurance is typically based on the pet’s age, breed and size and the location in which you are seeking insurance, so it may not be as price sensitive by breed,” said Dr. Liff. “For example, a 100-pound, mixed-breed dog living in New York City would cost more to insure than a Havanese living in Cleveland, Ohio.” Q: Which Insurance Plans Are Best for Purebred Dogs? A: Dr. Liff recommends that all pets have accident and illness coverage with an 80% to 90% reimbursement rate and a minimum annual coverage limit of $25,000, whether they’re purebred or not. Additional wellness coverage can often save you money on preventive care, which can help keep your purebred dog healthy. When investigating pet insurance plans for your purebred dog, research hereditary or congenital conditions common to your pet’s breed, consider their health history and review each policy carefully to ensure your dog is well-protected. Q: Which Insurance Plans Are Best for Mixed-Breed Dogs? A: While mixed-breed dogs have a lower risk for genetic or inherited medical conditions, quality veterinary care, especially for unexpected illnesses and injuries, is expensive. The right pet insurance plan can cut the cost of all your mixed-breed dog’s health needs, from routine veterinary services to emergency care. Coverage and plan options — as well as cost — can vary widely depending on the provider and the specific policy, so it’s important to spend time researching your options to help you find the best pet insurance plan for your mixed-breed dog. Q: What Tips Do You Have For Owners of Purebred Dogs? A: “All pets — regardless of breed — need regular veterinary care to stay healthy,” said Dr. Liff. She advises following your veterinarian’s recommendations regarding your pet’s preventive care and annual diagnostics to monitor your pet’s health and identify problems before they become more serious. She also recommends keeping your pet up-to-date on their vaccinations and parasite screenings, and administering year-round flea, tick and heartworm preventives to protect your pet. Q: What Tips Do You Have for Owners of Mixed-Breed Dogs? A: Many pet insurance providers cover pets as young as 8 weeks old, so purchase pet insurance for your mixed-breed dog when they are young and healthy. Most pet insurance plans do not cover pre-existing conditions, and purchasing coverage for your young pet means your plan will likely cover future health conditions. Regardless of whether you bring a purebred or mixed-breed dog into your home and heart, you want to ensure they live a long, healthy life by your side. Purchasing a health insurance policy can help you provide for their medical needs, from routine to unexpected, so they stay in excellent health.
Author: medicalviseAdmin
JOPLIN, Mo. — Blood donors in Joplin are being offered tickets to a Springfield Cardinals game. This week only, September 5 through September 8, successful donors will score free tickets to the Cardinals vs. Tulsa game at Hammons Field in Springfield. In addition to baseball game tickets, donors will also receive free admission to the Dickerson Park Zoo and a T-shirt. “As we come out of the Labor Day holiday weekend, we are rallying our community baseball fans to help build back blood reserves for area patients who are counting on it,” CBCO Media Relations Representative Michelle Teter said. “Many of our summer donors that gave during our ‘Bleed Red’ event in the summer are now eligible again. This is the perfect time to come in, donate blood, save a life, and reap the benefits of one last trip to the ballpark in 2023.” Community Blood Center of the Ozarks’ (CBCO) Joplin donor center is open Tuesday through Thursday between 11 a.m. and 6 p.m. and on Friday between 8 a.m. and 2 p.m. CBCO is the only supplier of blood, platelets, and plasma to 44 area healthcare facilities.
NEWTON, Mass., Sept. 5, 2023 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company’s senior management team will participate in the following investor conferences in September: H.C. Wainwright 25th Annual Global Investment ConferenceFormat: Podium presentationDate: Monday, September 11, 2023Time: 12:30 p.m. ET Morgan Stanley 21st Annual Global Healthcare ConferenceFormat: Fireside chatDate: Tuesday, September 12, 2023Time: 5:30 p.m. ET Baird 2023 Global Healthcare ConferenceFormat: Fireside chatDate: Wednesday, September 13, 2023Time: 2:00 p.m. ET A live webcast of the presentation and fireside chats, along with accompanying slides, can be accessed under “Events & Presentations” in the Investor section of the Company’s website, http://investors.karyopharm.com/events-presentations, and will be available for replay for 90 days following each presentation. About Karyopharm Therapeutics Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is a commercial-stage pharmaceutical company pioneering novel cancer therapies. Since its founding, Karyopharm has been an industry leader in oral Selective Inhibitor of Nuclear Export (SINE) compound technology, which was developed to address a fundamental mechanism of oncogenesis: nuclear export dysregulation. Karyopharm’s lead SINE compound and first-in-class, oral exportin 1 (XPO1) inhibitor, XPOVIO® (selinexor), is approved in the U.S. and marketed by the Company in three oncology indications and has received regulatory approvals in various indications in a growing number of ex-U.S. territories and countries, including Europe and the United Kingdom (as NEXPOVIO®) and China. Karyopharm has a focused pipeline targeting multiple high unmet need cancer indications, including in multiple myeloma, endometrial cancer, myelodysplastic neoplasms and myelofibrosis. For more information about our people, science and pipeline, please visit www.karyopharm.com, and follow us on Twitter at @Karyopharm and LinkedIn. SOURCE Karyopharm Therapeutics Inc.
The “Cardiovascular Monitoring Devices Market” Research Report gives a comprehensive overview of the market, highlighting the key market growth trends, new opportunities, threats, and drivers. Also given is the market’s CAGR value. Market research on Cardiovascular Monitoring Devices provides qualitative and quantitative analysis of company profiles, development updates, industry size, and market share across all over geographical regions. The report also provides a comprehensive primary analysis of the market with an emphasis on the supply chain, segmentation, application types, key players, and industry sectors of the market. It offers a thorough grasp of the entire ecosystem, together with in-depth knowledge of important market categories and the impact they have on particular regions. Ask for Sample Report Market Analysis and Insights: Global Cardiovascular Monitoring Devices Market The global Cardiovascular Monitoring Devices market size was valued at USD 24459.88 million in 2021 and is expected to expand at a CAGR of 4.03 percentage during the forecast period, reaching USD 30994.47 million by 2027.Cardiovascular Monitoring Devices usually refers to continuous or intermittent monitoring of cardiac activity and assessment of the patient’s condition relative to his or her heart rhythm. Major Players in Cardiovascular Monitoring Devices market are: Medtronic PLC FUKUDA DENSHI Co., Ltd., Philips Healthcare LivaNova PLC Welch Allyn, Inc. St. Jude Medical, Inc. Siemens Healthcare Boston Scientific Corporation GE Healthcare BIOTRONIK SE and Co. KG Get a Sample Copy of the report: https://www.absolutereports.com/enquiry/request-sample/21439187 Cardiovascular Monitoring Devices Market by Types: ECG systems Holter Monitors Event Monitors Others Cardiovascular Monitoring Devices Market by Applications: Hospital Clinic Others Cardiovascular Monitoring Devices Market Key Points: Define, describe and forecast Cardiovascular Monitoring Devices product market by type, application, end user and region. Provide enterprise external environment analysis and PEST analysis. Provide strategies for company to deal with the impact of COVID-19. Provide market dynamic analysis, including market driving factors, market development constraints. Provide market entry strategy analysis for new players or players who are ready to enter the market, including market segment definition, client analysis, distribution model, product messaging and positioning, and price strategy analysis. Keep up with international market trends and provide analysis of the impact of the COVID-19 epidemic on major regions of the world. Analyze the market opportunities of stakeholders and provide market leaders with details of the competitive landscape. To Understand How Covid-19 Impact Is Covered in This Report – https://www.absolutereports.com/enquiry/request-covid19/21439187 Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast : United States Europe China Japan India Southeast Asia Latin America Middle East and Africa Outline Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment. Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained. Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered. Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world. Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type. Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market. Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry. Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic. Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc. Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points. Chapter 11 introduces the market research methods and data sources. Major Questions Addressed in the Report: What is the anticipated growth rate of the Cardiovascular Monitoring Devices market and what factors are influencing this growth in the next years? What is the market’s perception and adoption rate of the various kinds of Cardiovascular Monitoring Devices? How are government initiatives and regulatory measures influencing the expansion of the Cardiovascular Monitoring Devices market? What are the top 5 competitors’ market shares, and how are they projected to change over the next few years? What new developments and technology are there in the Cardiovascular Monitoring Devices market, and how are they changing the business environment? What impact do macroeconomic variables like GDP, inflation, and exchange rates have on the Cardiovascular Monitoring Devices market? What are the supply chain and logistical issues the participants in the Cardiovascular Monitoring Devices market are dealing with? How are the dynamics of the Cardiovascular Monitoring Devices market being impacted by shifting customer behaviour and preferences? What potential dangers and pitfalls could accompany investing in the Cardiovascular Monitoring Devices market, and how can they be avoided? Inquire or Share Your Questions If Any before the Purchasing This Report – https://www.absolutereports.com/enquiry/pre-order-enquiry/21439187 Detailed TOC of Global Cardiovascular Monitoring Devices Industry Research Report 1 Cardiovascular Monitoring Devices Market Overview 1.1 Product
New research from The Ohio State University College of Medicine finds COVID-19 vaccine mandates are highly effective at reducing the spread of the virus and increasing immunity in a university setting. The study, published in the journal PLOS Pathogens, found net viral loads among all community members declined after university vaccine requirements went into effect. Masking, isolation and antibodies from getting sick weren’t enough to decrease infection rates. “Before the vaccine was required, the virus was becoming more concentrated in saliva and easier to spread to vulnerable populations like young children and older adults,” said Richard Robinson, principal investigator and associate professor in the Department of Microbial Infection and Immunity. “Once the requirements were in place, we saw on average a 100% decrease in virus in saliva and up to 12,000% increase in antibody levels to block its spread.” Researchers looked at data generated as part of The Ohio State University’s COVID monitoring program, which occurred from August 2020 to June 2022. As part of this program, saliva specimens were collected on a weekly basis from asymptomatic students, staff and faculty. More than 850,000 diagnostic COVID tests were performed. “The COVID monitoring program focused on asymptomatic adults for several reasons,” Robinson said. “Asymptomatic infections are more common in young adults, asymptomatic individuals would still spread the virus and the isolation of symptomatic individuals alone wasn’t enough to flatten the curve of COVID infections.” Six Ohio State campuses in Columbus, Newark, Mansfield, Lima, Marion and Wooster participated in the monitoring program. The data found COVID positivity in asymptomatic adults occurred in waves which mirrored the infection rates in the regions surrounding the university campuses and were driven by newly emerging variants such as delta and omicron. “At the time, there was growing concern that college students were creating new waves and peaks in infection when they would return to communities after distance learning and breaks in their education, but that wasn’t the case,” Robinson said. “The rates of infection were already increasing when classes resumed, even in rural areas.” Additionally, researchers explored the causes of breakthrough infections in vaccinated people. They compared the antibody responses of uninfected vaccinated people with those of infected vaccinated people. The study found breakthrough infections in vaccinated people were not due to an absence of antibodies but depend on antibody levels at the time of exposure, the neutralizing ability of the antibodies and the amount of virus to which the person is exposed. Future research will focus on the conditions that make people more resistant to COVID infection. Other researchers involved in this study were Marlena R. Merling, Amanda Williams, Najmus S. Mahfooz, Marisa Ruane-Foster, Jacob Smith, Jeff Jahnes, Leona W. Ayers, Jose A. Bazan, Alison Norris, Abigail Norris Turner, Michael Oglesbee, Seth A. Faith and Mikkel B. Quam.
At least six people have died on the East Coast this summer after being infected with “flesh-eating” bacteria in warming waters. Health officials say two people in Connecticut, one person in New York and three in North Carolina died in July and August from Vibrio vulnificus, a potentially deadly bacterium. The U.S typically sees a handful of deaths in Gulf states, but it’s rare for deaths to be spiking in East Coast states. In response, the Centers for Disease Control and Prevention issued a health advisory to warn doctors, laboratories and public health departments to be on the lookout for these infections. “The sky is not falling, but be careful, pay attention and take it seriously if you have an infection and get it treated,” Dr. Rita Colwell, a microbiologist and marine expert at the University of Maryland at College Park and at Johns Hopkins University Bloomberg School of Public Health, told ABC News. Vibrio bacteria cause an estimated 80,000 illnesses each year in the U.S., according to the CDC. In particular, Vibrio vulnificus can lead to life-threatening infections. Between 150 and 200 infections are reported to the CDC every year with about one in five people dying — often within a day or two of becoming ill, the agency said. A Vibrio Vulnificus bacterium. Universal Images Group via Getty Images These bacteria are naturally occurring in saltwater and brackish waters and more abundant in the summer months, between May and October. “Most often than not, this bacterium is going to have a coastal origin, meaning that somebody would visit coastal waters for recreation, they may have a wound or like exposed skin,” Dr. Antarpreet Jutla, an associate professor in the department of environmental engineering science at the University of Florida, told ABC News. “And then these bacteria basically get into those holes and then a person can get infected.” Eating raw or undercooked shellfish such as oysters that live in coastal waters can also increase the risk of an infection caused by Vibrio vulnificus. Symptoms of Vibrio vulnificus infection can include fever, nausea, vomiting, stomach cramps and watery diarrhea. For those who have a bloodstream infection, symptoms include fever, chills, low blood pressure and blistering skin lesions, For a wound infection, a patient might have redness, pan, swelling, warmth, fever discoloration, and discharge. Those with wound infections can suffer necrotizing fasciitis, which is when the flesh around an open wound dies. Treatment involves antibiotics and replacing liquids lost through diarrhea. Necrotizing fasciitis can sometimes lead to limb amputation. Many of the infections in Connecticut, New York and North Carolina were contracted due to open wounds that were exposed to coastal waters, according to the CDC. Some of the infections were due consuming of raw or undercooked seafood — and other infections had unclear origins. To reduce the risk, health officials recommend people stay out of saltwater and brackish water if they have an open wound. If an open wound does come into contact with this water, wash the wound thoroughly with clean, running water and soap. Additionally, avoid eating or coming into contact with raw shellfish. “If you got cut and it’s healed over, that’s not a problem,” Tessa Getchis, an extension educator with Connecticut Sea Grant & University of Connecticut Extension, told ABC News. “If it’s an open wound, they want to wait until that wound is closed.” She added that it’s not enough to cover the wound with a waterproof bandage and that people with open wounds should avoid the water completely. Jutla said that with more populations settling along the coasts and warming temperatures making coastal waters warmer for longer, it could be an issue in the future. He and a team of researchers at the University of Florida sampled water in the Fort Myers region after Hurricane Ian in 2020 and found “extensive sampling” of Vibrio vulnificus, even after four weeks of sampling. With the recent passing of Hurricane Idalia in southern states, experts say that floodwaters and storm surges may leave an opportunity for people to become infected with Vibrio vulnificus. “If I were in that region, I would not wander around in flooded waters,” Jutla said. “I would be very careful in in in going to sea water coastal waters .”
Hypovitaminosis D, or too little vitamin D, is fairly common in patients with systemic lupus erythematosus (SLE) and is linked with high inflammatory activity and decline in bone mineral density (BMD), according to study findings published in Lupus Science and Medicine. Status of vitamin D was not linked with patient age or disease course. Vitamin D deficiency in patients with SLE is known to be linked with decreased BMD, but scientific information on the relationships between vitamin D level and markers of bone turnover, disease duration, and glucocorticoid (GC) therapy is limited. sun in a blue sky with clouds Researchers aimed to ascertain vitamin D levels in patients with SLE and analyze their relationship to BMD and the disease course. They hypothesized that vitamin D deficiency and insufficiency is widespread among patients with SLE and might be linked with long-term use of GCs and sunscreens, kidney damage, vitamin D antibody presence, and more. A total of 101 patients with SLE and 29 people in the control group were included in the study. Study participants were tested for vitamin D level, erythrocyte sedimentation rate (ESR), C reactive protein (CRP), IL-6, osteocalcin (OC), and collagen type I C-terminal telopeptide (CTX), and dual-energy X-ray absorptiometry was performed to evaluate BMD in the lumbar spine and hip. The mean (SD) serum vitamin D level was 18.98 (0.88) ng/mL, and women possessed 25.42% lower vitamin D levels than men (P < .05). No correlation was observed between vitamin D levels and cumulative dose of GCs (r = –0.26) and serum inflammatory markers, especially CRP (r =–0.39). IL-6 (r = –0.37) and ESR (r =–0.15). Vitamin D level was linked with bone turnover markers (BTMs). In women of reproductive age with vitamin D deficiency, BMD of the lumbar spine and the hip was 9.5% to 23.1% greater than in those with no vitamin deficiency, respectively, and the mean lumbar spine Z-score in those with vitamin D insufficiency and deficiency was 2.0 and 2.9 times lower, respectively, than in patients with normal vitamin D level. Advertisement “Although the lowest 25(OH)D level was found in the group with the shortest disease duration, in general, the levels of the vitamin tested had no associative relation to disease duration,” explained the researchers. Additionally, the literature data also presented no correlation between disease duration and vitamin D levels. The researchers also found a strong associative inverse correlation (r = –0.26) of cumulative dose of GCs with vitamin D levels, so in the group of patients with a cumulative dose of GCs greater than 42.8 g, the average vitamin D level was 31.7% lower than in the patient group with a cumulative dose less than 42.8 g. The proportion of people in the high-dose GC group with vitamin D deficiency was 72.5%, while it was 52% in the low-dose GC group. “Another pathogenetic factor adversely affecting vitamin D levels in patients with SLE is the systemic inflammatory process,” said the researchers. Correlation analyses uncovered more evidence that the lowered 25(OH)D level is linked with inflammatory activity. Since excessive autoantibody synthesis by B lymphocytes is a main element in pathogenesis of multiple autoimmune diseases, especially SLE, it can be determined that vitamin D influence on B cells causes inhibition of autoantibody synthesis. “Thus, it is obvious that vitamin D can regulate at least some immune reactions, and its role is predominantly anti-inflammatory, which helps to prevent hyperinflammation and autoimmunity,” continued the researchers. The researchers noted that all mechanisms of a relationship between SLE activity, vitamin D levels, BMD, and bone synthesis markers and resorption are not specifically known and need further investigation. This study had some limitations. First, it was undertaken with only 1 measurement of serum 25 (OH)D levels, and it included mostly patients with high inflammatory activity. “Hypovitaminosis D was associated with high inflammatory activity (SLEDAI, ESR, CRP, IL-6), severity of organ damage (DI), cumulative dose of GCs, BTMs (OC, CTX) and BMD. Vitamin D status was not associated with the patient’s age or disease duration,” concluded the researchers. Reference Shevchuk S, Marynych L, Malovana T, Denyshchych L. Vitamin d level in patients with systemic lupus erythematosus: its relationship to disease course and bone mineral density. Lupus Sci Med. Published online August 9, 2023. doi:10.1136/lupus-2023-000968
Topline The Centers for Disease Control and Prevention issued a health alert Friday warning healthcare professionals to be on the lookout for fatal infections of the “flesh-eating bacteria” Vibrio vulnificus, as warmer waters and Hurricane Idalia may cause a spike in cases. Key Facts Vibrio vulnificus can be contracted by eating raw seafood like oysters, or if an open wound comes into contact with raw seafood or its drippings, salt water or brackish water—a mix between fresh and salt water. At least five people died from fatal vibrio infections in New York, Connecticut and North Carolina between July and August, according to the CDC report, while the Florida Department of Health reported 26 cases and five deaths statewide between January and August. There have been three confirmed cases since July 1 in Connecticut: All three patients were hospitalized and between the ages of 60 and 80, while two confirmed they swam in brackish water in Long Island Sound and the third consumed out-of-state raw oysters, though only one died, according to the state Department of Public Health. Only one fatal case was identified in New York while three fatal cases were reported in North Carolina, where two people were exposed to brackish water in North Carolina and another eastern state while the third person was exposed to brackish North Carolina water and ate personally caught seafood, state officials said. The bacteria live in coastal waters, naturally separate from shellfish during hotter months and populate in the warm water, so the CDC advised in its health alert to avoid open water if people have an open wound or cut. Hurricanes, storm surges and floods also increase exposure to the bacteria by bringing the coastal waters inland, like in 2022, when 38 cases and 11 vibriosis-related deaths were reported after Hurricane Ian. What To Watch For Though no vibrio cases have been reported since Hurricane Idalia, Florida Department of Health press secretary Jae Williams told NBC the state began warning residents of potential infection “as soon as the state of emergency was declared.” Crucial Quote “People should consider the potential risk of consuming raw oysters and exposure to salt or brackish water and take appropriate precautions,” Manisha Juthani, the Connecticut Department of Health commissioner said. Big Number 80,000. That’s how many Americans the CDC estimates get a vibrio infection each year, resulting in 100 deaths. Key Background Though anyone can get sick from the bacteria, the elderly and people who have diabetes, HIV, liver disease, thalassemia or cancer are the most at risk of developing severe complications. People who had recent stomach surgery, take medicine to reduce stomach acid and receive immune-supressing therapy also face a risk. Vibrio symptoms include watery diarrhea, stomach cramps, nausea, fever and vomiting. Wound infection symptoms include pain, swelling, redness, discharge, discoloration and warmth. Blood infection symptoms may present as chills, fever, blistering skin infection or dangerously low blood pressure. Though there’s no cure for vibrio infection, antibiotics and other treatments are used to treat skin infection from spreading and other symptoms, like shock. These treatments include fluid drainage, cleaning dead skin from wounds, oxygen therapy, medication for low pressure, intravenous fluids and potential amputation. There’s about a one in four chance a vibrio wound infection will turn fatal, researchers report. Sometimes, infection can turn into necrotizing fasciitis, a severe, “flesh-eating” infection that causes the skin around a wound to die. In other severe cases, vibrio infection can lead to septicemia, a very fatal bloodstream infection that can lead to sepsis, which only has a 50% survival rate. Tangent U.S. vibrio infections on the East Coast have increased over the past 30 years, rising from 10 infections a year in 1988 to 80 in 2018, according to research published in March in Scientific Reports. Infections north of Georgia used to be rare and were typically localized to the southern Atlantic coast and the Gulf of Mexico. However, the researchers pointed to warmer weather and an aging population as the causes for an increase in cases on the East Coast. They predicted cases could spike as high as 140 and 200 cases on the East Coast every year by the end of the century. The U.S. experienced a record-breaking summer this year, seeing over 6,500 daily heat records and sometimes fatally hot temperatures. Parts of the North Atlantic ocean witnessed a category four marine heat wave in July, causing periods of unusually extreme temperatures and warm waters. Ocean temperatures were warming up 24% faster last decade compared to previous ones, according to a 2019 study published in Science. Further Reading Flesh-Eating Bacteria Are Migrating Up The East Coast As Climate Change Warms Sea, Scientists Say (Forbes) What Warmer Oceans Mean For The Environment—From Dangerous Storms To Severe Flooding (Forbes) Record-Breaking Summer: Over 6,500 Daily U.S. Heat Records Fell—Here Are The Biggest Ones (Forbes)
A number of cases of flesh-eating Vibrio vulnificus infection has prompted the Centers for Disease Control and Prevention to issue a health advisory to doctors, laboratories and health departments to be on the alert for such bacterial infections and to see that treatment is provided quickly. The V. vulnificus bacteria can cause severe wound and foodborne infections. The Washington Post reported that 13 people died recently from V. vulnificus infections, which can come from undercooked shellfish or from contact with the bacteria from open wounds — even very small ones. And the geographic area where the bacteria lurk is spreading, experts say. This year, of confirmed deaths linked to the bacterial infection, seven have been in Florida, three in North Carolina, two in Connecticut and one in New York, the Post reported. “Many of these infections were acquired after an open wound was exposed to coastal waters in those states. Some of these infections were associated with consumption of raw or undercooked seafood or had unclear etiology,” per the CDC. People can also be infected through undercooked shellfish that comes from areas where the bacteria can be found, so the geographic risk is not limited to coastal regions. CNN reported that “during July and August, as the U.S. saw widespread heatwaves and above-average coastal sea surface temperatures,” more people were infected. Diagnosis and treatment must be swift because of the speed with which the infection advances, per the CDC. About Vibrio infections Infections from different species of Vibrio bacteria are common, causing about 80,000 illnesses — most often diarrhea — in the U.S. alone each year. But Vibrio vulnificus is an entirely different story for its ability to cause what the CDC calls “life-threatening infections.” The CDC notes there are about 150-200 of those infections reported each year — and 20% of those infected died, “sometimes within 1-2 days of becoming ill.” Vibrio bacteria naturally live in coastal waters, including salt water. Typically, infections occur when people eat raw or undercooked shellfish. Oysters are especially prone to harboring the bacteria. Infections also occur when an open wound is exposed to salt water or brackish water that harbors Vibrio. An open wound exposed to undercooked or raw seafood can lead to infection, too. “Open wounds include those from a recent surgery, piercing, tattoo, and other cuts or scrapes — including those acquired during aquatic activity. Extreme weather events, such as coastal floods, hurricanes and storm surges, can force coastal waters into inland areas, putting people that are exposed to these waters — especially evacuees who are older or have underlying health conditions — at increased risk for Vibrio wound infections,” the advisory says. LiveScience reported that while infection is more common on the Gulf Coast, “increased coastal sea surface temperatures and widespread heatwaves this summer have coincided with the reported infections across the East Coast. Indeed, rising coastal water temperatures associated with climate change have been previously linked with increasing rates of Vibrio infections.” CDC reported that the range of V. vulnificus infections has spread north about 30 miles a year between 1988 and 2018 as temperatures have increased. And the number of infections in the East has increased eightfold. There are no known cases of person-to-person transmission. Wound infections take off quickly and kill skin and soft tissue, including muscles and nerves. Those infected may need surgery and intensive care. The bacteria have developed some antibiotic resistance, meaning treatment doesn’t always work to kill the bacteria once someone is infected, so prevention is vital. Staying safe To avoid exposure to what can be a deadly infection, the CDC recommends: Stay out of salt water or brackish water if you have any open wound or cut. If you get cut in the water, leave it immediately. If open wounds touch salt water, brackish water, or raw or undercooked seafood, wash them thoroughly with soap and clean running water. Then cover them entirely with a waterproof bandage. Cook raw oysters and other shellfish before eating them. Always wash with soap and water after handling raw shellfish. Seek medical care immediately for infected wounds.
Marcia de Rousse, who portrayed Dr. Patricia Ludwig in True Blood, has died aged 70. As Variety reports, the actor passed away in Altadena, California last Saturday (September 2) following a long illness. De Rousse appeared as the aforementioned character – a doctor for supernatural beings – in three episodes of the HBO original series. She first took on the role in an episode of season two called ‘Scratches’, and later returned in the show’s fourth and seventh seasons. In April, de Rousse wrote in a post on Facebook that she had suffered “a fall in [her] doctor’s office” which she said “would lead to [her] death”. She continued: “It caused my hiatal hernia to move to an area where it is now dangerous. Can’t eat, can’t breathe, just general misery. Palliative care comes soon, and we wait [to] turn into hospice and then to die. “Thank you all for being great friends. Love to you.” Additionally, de Rousse’s TV credits include St. Elsewhere, The Fall Guy and Schooled. She also acted in the 2003 comedy-drama film Tiptoes, playing Kathleen alongside the likes of Gary Oldman, Kate Beckinsale and Matthew McConaughey. Born in Doniphan, Missouri, de Rousse made her feature film debut in Under The Rainbow (1981), which was directed by Steve Rash. The film, set in 1938, starred Chevy Chase and Carrie Fisher. De Rousse’s final role was in The Disappointments Room, a 2016 psychological horror film starring Beckinsale and Lucas Till. True Blood ran for seven seasons between 2008 and 2014. In late 2020, it was announced that HBO was developing a reboot series with Alan Ball – the original creator and showrunner – on board as an executive producer. Earlier this year, however, HBO CEO Casey Bloys confirmed that despite the US network having developed some scripts, “nothing that felt like it got there” (via Collider).